Novo Nordisk A/S (B Shares) ADRhedged

Novo Nordisk A/S (B Shares) ADRhedged is offered by ADRhedged, a leading player in the field of passive investments.

The total expense ratio of Novo Nordisk A/S (B Shares) ADRhedged is 0.19%, which means that investors pay 19 USD per 10,000 USD in investment capital annually.

The ETF is listed in USD.

European investors may incur additional costs for currency exchange and transaction fees.

No, Novo Nordisk A/S (B Shares) ADRhedged does not comply with the EU UCITS investor protection directives.

The current average trading volume of Novo Nordisk A/S (B Shares) ADRhedged is 7,013.33.

Novo Nordisk A/S (B Shares) ADRhedged is domiciled in US.

The fund was launched on 1/7/2025.

The Novo Nordisk A/S (B Shares) ADRhedged mainly invests in Healthcare companies.

The NAV of Novo Nordisk A/S (B Shares) ADRhedged amounts to 26.34 M USD.

Investments can be made through brokers or financial institutions that provide access to trading ETFs.

The ETF is traded on the stock exchange, similar to stocks.

Yes, the ETF can be held in a regular securities account.

The ETF is suitable for both short-term and long-term investment strategies, depending on the investor's goals.

The ETF is valued on a daily stock exchange basis.

Information on dividends should be requested from the provider's website or your broker.

The risks include market fluctuations, currency risks, and the risk associated with smaller companies.

The ETF is obligated to report regularly and transparently on its investments.

The performance can be viewed on Eulerpool or directly on the provider's website.

Further information can be found on the official website of the provider.